Covidien plc. Press Releases

Covidien Board of Directors Approves Separation of Pharmaceuticals Business and Declares Dividend of Mallinckrodt Ordinary Shares
05/24/2013 7:00AM - Business Wire

Covidien and Mallinckrodt to Present at Deutsche Bank Conference
05/23/2013 7:00AM - Business Wire

Covidien’s Technology Platform to Diagnose Early Lung Cancer Part of New Guidelines of American College of Chest Physicians
05/21/2013 6:59AM - Business Wire

Covidien Receives FDA 510(k) Clearance for Nellcor™ Pulse Oximetry Motion Claims
05/20/2013 8:00AM - Business Wire

Covidien Announces Pricing of $750 Million Senior Notes Offering
05/13/2013 4:01PM - Business Wire

Covidien Announces Senior Notes Offering
05/13/2013 9:00AM - Business Wire

Covidien and Mallinckrodt to Present at Bank of America Merrill Lynch Conference
05/08/2013 7:00AM - Business Wire

Covidien Appoints Jacqueline Strayer Senior Vice President, Corporate Communications
05/06/2013 9:00AM - Business Wire

Covidien Announces First Full-Year Outlook for Mallinckrodt plc
05/03/2013 4:01PM - Business Wire

Covidien Announces 2013 Guidance and Provides Historical Financial Statements Adjusted for Discontinued Operations
05/03/2013 4:01PM - Business Wire

Covidien Reports Second-Quarter Results
04/26/2013 6:00AM - Business Wire

Covidien Introduces New Surgical Access Devices at SAGES 2013
04/17/2013 7:00AM - Business Wire

Covidien Launches New Shiley™ Neonatal and Pediatric Tracheostomy Tubes
04/15/2013 8:00AM - Business Wire

Covidien and VIDA Diagnostics Collaborate to Expand Minimally Invasive Treatment of Lung Disease
04/11/2013 7:00AM - Business Wire

Mallinckrodt International Finance S.A. Announces Pricing of Senior Unsecured Notes Offering
04/08/2013 5:44PM - Business Wire

Mallinckrodt International Finance S.A. Announces Private Offering of Senior Unsecured Notes
04/08/2013 9:22AM - Business Wire

Covidien Awarded $176.5 Million Verdict in Patent Litigation against Ethicon Endo-Surgery
03/29/2013 12:54PM - Business Wire

Nuvo Research announces 2012 Fourth Quarter & Year-End Results
03/27/2013 5:00PM - PR Newswire

Mallinckrodt Launches Additional Dosage Strengths of Generic CONCERTA® in U.S.
03/25/2013 8:30AM - Business Wire

Covidien Expands Share Repurchase Program and Declares Quarterly Cash Dividend
03/21/2013 7:00AM - Business Wire

Covidien Announces Results from 2013 Annual General Meeting
03/20/2013 7:37AM - Business Wire

Covidien Announces Nominees to Board of Directors for Mallinckrodt Pharmaceutical Business
03/15/2013 8:30AM - Business Wire

A Forward Look, The Year Ahead - Research Report on PepsiCo, Inc., The Coca-Cola Company, Covidien plc, Medtronic, Inc. and Monster Beverage Corp
03/15/2013 8:00AM - PR Newswire

Covidien plc to Report Second-Quarter Results on April 26, 2013
03/14/2013 7:00AM - Business Wire

Covidien Launches Three New Hernia Care Products at American Hernia Society Annual Meeting
03/13/2013 7:00AM - Business Wire